Researchmoz added Most up-to-date research on "Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast-2022" to its huge collection of research reports.
The Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast-2022 report provides an overview of the disease, epidemiology and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. According to DelveInsight, the global AHF market was $188 million in 2015 and expected to grow to $929 million by 2020 with and compound annual growth rate (CAGR) of 17%.
Acute Heart Failure (AHF) is the rapid onset of sign and symptoms of Heart Failure resulting in need and urgent therapy or hospitalization. The AHF primarily includes the symptoms of pulmonary congestion or peripheral perfusion due to cardiac or vascular dysfunction. Based on the recommended guidelines, loop diuretics are the most common treatment for the Acute Heart Failure in patients with dyspnoea caused by pulmonary oedema, more than 90% of patients admitted with AHF receives this drug.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=720128
Key Coverage and Benefits:
- The report will help in developing business strategies by understanding the trends shaping and driving the global Acute heart failure (AHF) market.
- Identifying patient populations in the global Acute heart failure (AHF) market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the best opportunities for Acute heart failure (AHF) therapeutics in each of the markets covered.
- To understand the future market competition in the global Acute heart failure (AHF) therapeutics market and Insightful review of the key market drivers and barriers.
Scope of the Report:
- Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
- Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2022.
- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2015-2022.
- It also provides Acute heart failure (AHF) for United States, EU5 and Japan from 2015 and forecasted Market to 2022.
Table of Contents
Report Introduction
Executive Summary
Key findings
Acute Heart Failure Market Overview at a Glance
Worldwide Market Size of Acute Heart Failure in 2015 (MM)
Worldwide Market Size of Acute Heart Failure in 2022 (MM)
Acute Heart Failure
Disease Overview
Treatment Goals
Management
Treatment Algorithms
Epidemiology and Patient Population
Key Findings
Overview
Diagnosed Hospitalization Cases of Acute Heart Failure
United States
5EU and Japan
Total number of Hospitalization Cases for Acute Heart Failure in 7 Major Markets
Current Clinical Practice
Conventional Therapies for Acute Heart Failure Management
In Cases of Pulmonary Oedema
In cases of Hypotension and Cardiogenic Shock
In case of Hypertension
Treatment after Stabilization
Acute Novel Therapies
Carperitide
Product Profile
Advantages & Disadvantages
Cost of Therapy
Drug Sales
Carperitide Historical Sales and Forecasted Sales (2015-2022)
Acute Heart Failure-Global Market Assessment
Key Findings
Global Acute Heart Failure Market
Market Overview
Global Market Sales by Treatment Setting in AHF, 2015-2022
Total Acute Heart Failure Drug Sales
Timeline of Key Market events for Acute Heart Failure
Acute Heart Failure-United States Market Assessment
US Market Overview
United States Market Sales by Treatment Setting in AHF, 2015-2022
United States Market Share by Treatment Setting in AHF, 2015-2022
Acute Heart Failure-France Market Assessment
France Market Overview
France Market Sales by Treatment Setting in AHF, 2015-2022
France Market Share by Treatment Setting in AHF, 2015-2022
Acute Heart Failure-Germany Market Assessment
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=720128
The Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast-2022 report provides an overview of the disease, epidemiology and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. According to DelveInsight, the global AHF market was $188 million in 2015 and expected to grow to $929 million by 2020 with and compound annual growth rate (CAGR) of 17%.
Acute Heart Failure (AHF) is the rapid onset of sign and symptoms of Heart Failure resulting in need and urgent therapy or hospitalization. The AHF primarily includes the symptoms of pulmonary congestion or peripheral perfusion due to cardiac or vascular dysfunction. Based on the recommended guidelines, loop diuretics are the most common treatment for the Acute Heart Failure in patients with dyspnoea caused by pulmonary oedema, more than 90% of patients admitted with AHF receives this drug.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=720128
Key Coverage and Benefits:
- The report will help in developing business strategies by understanding the trends shaping and driving the global Acute heart failure (AHF) market.
- Identifying patient populations in the global Acute heart failure (AHF) market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the best opportunities for Acute heart failure (AHF) therapeutics in each of the markets covered.
- To understand the future market competition in the global Acute heart failure (AHF) therapeutics market and Insightful review of the key market drivers and barriers.
Scope of the Report:
- Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
- Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2022.
- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2015-2022.
- It also provides Acute heart failure (AHF) for United States, EU5 and Japan from 2015 and forecasted Market to 2022.
Table of Contents
Report Introduction
Executive Summary
Key findings
Acute Heart Failure Market Overview at a Glance
Worldwide Market Size of Acute Heart Failure in 2015 (MM)
Worldwide Market Size of Acute Heart Failure in 2022 (MM)
Acute Heart Failure
Disease Overview
Treatment Goals
Management
Treatment Algorithms
Epidemiology and Patient Population
Key Findings
Overview
Diagnosed Hospitalization Cases of Acute Heart Failure
United States
5EU and Japan
Total number of Hospitalization Cases for Acute Heart Failure in 7 Major Markets
Current Clinical Practice
Conventional Therapies for Acute Heart Failure Management
In Cases of Pulmonary Oedema
In cases of Hypotension and Cardiogenic Shock
In case of Hypertension
Treatment after Stabilization
Acute Novel Therapies
Carperitide
Product Profile
Advantages & Disadvantages
Cost of Therapy
Drug Sales
Carperitide Historical Sales and Forecasted Sales (2015-2022)
Acute Heart Failure-Global Market Assessment
Key Findings
Global Acute Heart Failure Market
Market Overview
Global Market Sales by Treatment Setting in AHF, 2015-2022
Total Acute Heart Failure Drug Sales
Timeline of Key Market events for Acute Heart Failure
Acute Heart Failure-United States Market Assessment
US Market Overview
United States Market Sales by Treatment Setting in AHF, 2015-2022
United States Market Share by Treatment Setting in AHF, 2015-2022
Acute Heart Failure-France Market Assessment
France Market Overview
France Market Sales by Treatment Setting in AHF, 2015-2022
France Market Share by Treatment Setting in AHF, 2015-2022
Acute Heart Failure-Germany Market Assessment
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=720128
No comments:
Post a Comment